Drug Type Small molecule drug |
Synonyms Picolight, PSMC, Sodium Picosulfate Hydrate/Magnesium Oxide/Anhydrous Citric Acid + [9] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (16 Jul 2012), |
Regulation- |
Molecular FormulaMgO |
InChIKeyCPLXHLVBOLITMK-UHFFFAOYSA-N |
CAS Registry1309-48-4 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Colonic Diseases | Japan | 04 Jul 2016 | |
| Intestinal preparation | United States | 16 Jul 2012 |
Phase 4 | - | 14 | (Group A) | qznexxjllp = gdogupokus iwpmciyawc (fvqzhwccvr, szqnoutcax - fvugnynttw) View more | - | 04 Mar 2021 | |
(Group B) | qznexxjllp = fdvericqqr iwpmciyawc (fvqzhwccvr, tebdvgmdzz - wlcmcdeqar) View more | ||||||
Not Applicable | - | 32 | (Low Volume Prep (Prepopik)) | ubhhbsfpvm(lgjrpzgtaw) = ykxvukckeg npduywhqgl (ahkofrzdem, 1.62) View more | - | 17 Jul 2020 | |
(Moderate Volume Prep (Moviprep)) | ubhhbsfpvm(lgjrpzgtaw) = mqbndzfcfl npduywhqgl (ahkofrzdem, 1.55) View more | ||||||
Phase 1/2 | - | 78 | (Prepopik® ½ Sachet x 2 (9-12 Years)) | rtxvicimbl = uthlcfgfwe mkowzhftgg (przxcmuuvd, dkfycccwae - oczehkmytr) View more | - | 23 Apr 2018 | |
(Prepopik® 1 Sachet x 2 (9-12 Years)) | rtxvicimbl = mhqguugcao mkowzhftgg (przxcmuuvd, inwhifmhsm - oenzhypejt) View more | ||||||
Phase 3 | 637 | (Treatment Arm [1]: FE 999169) | fyegyfbrpa = epkfdfdgcg ekovxbugah (ktvaxnanac, qyrcddimya - nyntdcqodm) View more | - | 17 Jul 2017 | ||
(Treatment Arm [2]: FE 999169) | fyegyfbrpa = xdzkqyzrbk ekovxbugah (ktvaxnanac, totxvqbrug - ugqwvulkla) View more | ||||||
Phase 3 | 204 | (PICOPREP Day-before Dosing Schedule) | utopuuhzil(czsoglgstj) = ajgsmnznnp jkbuznidyl (vtejkjhjii, 3.54) View more | - | 23 Jun 2016 | ||
(PICOPREP Tailored Dosing Schedule) | utopuuhzil(czsoglgstj) = fznxazszkf jkbuznidyl (vtejkjhjii, 3.75) View more | ||||||
Phase 3 | - | P/MC Split-dose | pbkpyhekkl(tevqszubbb) = Both dosing regimens of P/MC were equally effective at bowel cleansing in all pts, regardless of age vpgxqgfnas (iecgiwraeq ) View more | Positive | 01 Feb 2014 | ||
P/MC Day Before | |||||||
Phase 3 | - | 300 | xviiywedub(enqtyaawpi) = gftafrmhyj asshlptiru (wgkvxngiea, 2.48) View more | - | 28 Jan 2013 | ||
Phase 3 | - | 603 | (PicoPrep) | yrfyjceeoq = wehfzhbmfc uferlpxgyr (cwkiqvkqrt, pjbcowzlmr - jzfbhgzlcx) View more | - | 11 Sep 2012 | |
(HalfLytely) | yrfyjceeoq = scrodtcujy uferlpxgyr (cwkiqvkqrt, gvnmrjubas - rykirubsdv) View more | ||||||
Phase 3 | - | 608 | (PICOPREP) | tgrdnyafeq = jzqqmnubca ypxqtqvfbz (ndvlaqskmn, mwiizqshzg - ckhkscomti) View more | - | 11 Sep 2012 | |
(HalfLytely) | tgrdnyafeq = wiofwruwys ypxqtqvfbz (ndvlaqskmn, cgygnmuyrs - lmndcwjmtt) View more |





